InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-53.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Janda Kim, Director. Insider active across 1 company, notably Sorrento Therapeutics, Inc.. Aggregated, 6 filings have been published. History available since 13 September 2021. The latest transaction was disclosed on 27 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
3,000 shares@ US$4.006.0% of flowCommon StockSEC:0001209191-21-071311
3,000 shares@ US$4.000.0025% mcap6.0% of flowCommon StockSEC:0001209191-21-071311:0
35,000 shares@ US$1.800.013% mcap30.5% of flowCommon StockSEC:0001209191-21-057957:0
35,000 shares@ US$1.8030.5% of flowCommon StockSEC:0001209191-21-057957
8,000 shares@ US$3.500.0057% mcap13.4% of flowCommon StockSEC:0001209191-21-055954:0
8,000 shares@ US$3.5013.4% of flowCommon StockSEC:0001209191-21-055954
6 of 6 declarations
About Janda Kim
Janda Kim is a Board Member at Sorrento Therapeutics, Inc. In this role, she participates in overseeing the company's activities and making strategic decisions. Kim brings her expertise to guide the direction of Sorrento and ensure compliance with governance standards. Her commitment to operational excellence is a valuable asset to the board.
